文献速递消化道肿瘤与早癌

钙摄入与结直肠癌风险:依据钙敏感受体(CASR)表达状态的分析

Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR).
PubMed 文献 · Gut · 2017-07-04

在护士健康研究与卫生专业人员随访研究的136249人中发生的779例结肠直肠癌病例中,采用免疫组化评估肿瘤CASR蛋白表达,并用Cox比例风险回归分析钙摄入与CASR阳性或阴性结直肠腺癌亚型风险的关联。总钙摄入量与结直肠癌风险呈负相关(≥1200 vs <600 mg/天:多变量HR=0.75,95%CI 0.60-0.95,趋势P=0.01),该负相关仅见于CASR阳性肿瘤(HR=0.67,95%CI 0.51-0.86,趋势P=0.003),未见CASR阴性肿瘤(HR=1.15,95%CI 0.75-1.78,趋势P=0.67),两亚型间异质性P=0.06。

要点

  • 总钙摄入量较高与结直肠癌风险降低相关(≥1200 vs <600 mg/天:HR=0.75,95%CI 0.60-0.95)。
  • 钙摄入与CASR阳性肿瘤风险降低相关(HR=0.67,95%CI 0.51-0.86),与CASR阴性肿瘤无关(HR=1.15,95%CI 0.75-1.78)。
  • CASR阳性与阴性亚型间异质性检验P=0.06。

核心结论

  • 分子病理流行病学数据提示较高钙摄入量与较低结直肠癌风险之间可能存在因果关系,并提示CASR可能介导钙的抗肿瘤作用。

研究设计与样本

  • 在护士健康研究与卫生专业人员随访研究的136249名参与者中发生的779例结肠直肠癌病例,采用免疫组化评估肿瘤CASR蛋白表达。
  • 采用重复测量Cox比例风险回归分析评估钙摄入与按CASR状态分型的结直肠腺癌亚型发病风险的关联。

主要发现

  • 总钙摄入量与结直肠癌风险呈负相关(≥1200 vs <600 mg/天:多变量HR=0.75,95%CI 0.60-0.95,趋势P=0.01)。
  • 总钙摄入量与CASR阳性肿瘤风险降低相关(≥1200 vs <600 mg/天:多变量HR=0.67,95%CI 0.51-0.86,趋势P=0.003)。
  • 总钙摄入量与CASR阴性肿瘤风险无关(≥1200 vs <600 mg/天:多变量HR=1.15,95%CI 0.75-1.78,趋势P=0.67)。
  • CASR阳性与阴性亚型间异质性检验P=0.06。
  • 钙摄入与CASR阳性而非CASR阴性肿瘤的较强负相关在不同性别、肿瘤部位和钙来源中基本一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although evidence suggests an inverse association between calcium intake and the risk of colorectal cancer, the mechanisms remain unclear. The calcium-sensing receptor (CASR) is expressed abundantly in normal colonic epithelium and may influence carcinogenesis. We hypothesized that calcium intake might be associated with lower risk of CASR-positive, but not CASR-negative, colorectal cancer. DESIGN: We assessed tumour CASR protein expression using immunohistochemistry in 779 incident colon and rectal cancer cases that developed among 136 249 individuals in the Nurses' Health Study and Health Professionals Follow-Up Study. Duplication method Cox proportional hazards regression analysis was used to assess associations of calcium intake with incidence of colorectal adenocarcinoma subtypes by CASR status. RESULTS: Total calcium intake was inversely associated with the risk of developing colorectal cancer (ptrend=0.01, comparing ≥1200 vs <600 mg/day: multivariable HR=0.75, 95% CI 0.60 to 0.95). For the same comparison, higher total calcium intake was associated with a lower risk of CASR-positive tumours (ptrend=0.003, multivariable HR=0.67, 95% CI 0.51 to 0.86) but not with CASR-negative tumours (ptrend=0.67, multivariable HR=1.15, 95% CI 0.75 to 1.78; pheterogeneity=0.06 between the CASR subtypes). The stronger inverse associations of calcium intake with CASR-positive but not CASR-negative tumours generally appeared consistent regardless of sex, tumour location and source of calcium. CONCLUSIONS: Our molecular pathological epidemiology data suggest a causal relationship between higher calcium intake and lower colorectal cancer risk, and a potential role of CASR in mediating antineoplastic effect of calcium.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Yang W, Liu L, Masugi Y, et al. Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut. 2017. PMID: 28676564. doi:10.1136/gutjnl-2017-314163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。